BCAB vs ROP · $5.9M cap vs P/E 41, rev $1.88B
Bioatla Inc (BCAB) versus Roper Technologies, Inc. (ROP) — a side-by-side from cached financials, not a winner call.
Bioatla Inc (BCAB) is a biotechnology company listed on NASDAQ.
Roper Technologies, Inc. (ROP) is a software - application company listed on US.
Latest reported BCAB revenue for 2023-09-30 was $0. Net income was -$33.3M. BCAB currently screens at market cap $5.9M.
Latest reported ROP revenue for 2024-12-31 was $1.88B. Net income was $462.3M. Revenue was up 6.4% from 2024-09-30 to 2024-12-31. ROP currently screens at market cap $61.61B and trailing P/E 41.3.
BCAB currently screens at market cap $5.9M. ROP currently screens at market cap $61.61B and trailing P/E 41.3.
Not investment advice. Open the BCAB and ROP stock pages for the full models.
Not investment advice.